Dr. Robert Goldstein

Robert Goldstein, MD, FACS is a Clinical Professor at Texas A&M College of Medicine at Texas A&M Health Science Center, Dallas. He is Medical Director of the Liver and Pancreas Disease Center at the Annette C. and Harold C. Simmons Transplant Institute. He is also Chief of Hebatobilliary Surgery and Director of the General Surgery Residency Program at Baylor University Medical Center, part of Baylor Scott & White Health. Dr. Goldstein's clinical interests include liver cancer, bile duct cancer and bile duct injuries. He provides immediate evaluation and medical management of patients with newly diagnosed benign and cancerous liver lesions. He and a team of transplant and oncologic surgery specialists work together to offer aggressive advanced treatments. With 30 years of experience in a high-volume transplant center, Dr. Goldstein is one of the most practiced hepatobilliary surgeons in the nation. Dr. Goldstein received his medical degree from the University of Tennessee Health Science Center in Memphis. He completed his residency at West Virginia University School of Medicine. He went on to start a transplant fellowship at the University of Pittsburgh and completed the transplant fellowship at Baylor University Medical Center in Dallas where he has dedicated his entire medical career to the care and treatment of liver cancer patients and liver transplant patients. Read more about Dr. Goldstein's publications on PubMed.gov and the Baylor Health Sciences Library. Read more about Dr. Goldstein's publications. Dr. Goldstein has been named one of D Magazine’s Best Docs at least 15 times earning him a place on D Magazine’s Hall of Fame list. Dr. Goldstein has been named one of Texas Monthly's Texas Super Doctors for the past 15 years earning him a place on Texas Monthly's Legacy list.

Dr. Goldstein is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Progressive Familial Intrahepatic Cholestasis Type 2, Progressive Familial Intrahepatic Cholestasis Type 1, Liver Transplant, and Splenectomy.

Dr. Goldstein is board certified in Transplant Surgery- American Board Of Surgery/General Surgery, - American Board Of Surgery/General Surgery, General Surgery- American Board Of Surgery/General Surgery, Transplant Surgery- American Board Of Surgery, and General Surgery- American Board Of Surgery. He is actively involved in clinical research, co-authoring 16 peer reviewed articles.